Jim Cramer says this former Covid market darling is finally investable again

1 day ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

1 day ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

2 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

2 days ago

Medicare will start covering obesity drugs. Here's what patients should know

2 days ago

French biotech stock soars 40% after new data on experimental medicine

2 days ago

FDA names first companies chosen for faster review of new manufacturing plants

2 days ago

Medicare is about to cover obesity drugs — but many seniors may not know it yet

4 days ago

Estrogen patches are hard to find, and it may not be resolved any time soon

6 days ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

7 days ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

8 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

8 days ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

9 days ago

SNAP restrictions could change what shoppers buy — and food giants are watching

12 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

13 days ago

What this biotech's volatile stock price tells you about the weight loss market right now

13 days ago

UniQure to seek FDA approval for Huntington's disease gene therapy in reversal

13 days ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

16 days ago

Centene to offer buyouts to some employees as health insurer cuts costs

17 days ago

Drugmakers race to find a place in the next wave of obesity drugs

19 days ago

CVS Health executives on reducing healthcare's biggest pain points

19 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

21 days ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

22 days ago

The space race is coming for pharma: Why drug development is heading to orbit

22 days ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

23 days ago

Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

24 days ago

GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors

24 days ago

Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says

24 days ago

Weight loss drug maker sinks 23% after new safety data spooks investors

24 days ago

U.S. confirms second Texas screwworm case, Canada restricts livestock imports

26 days ago

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

27 days ago

Warren Buffett disciple Guy Spier's rare cancer changed how he values everything

27 days ago